Author information
Authors and Affiliations
Additional information
Received: July 12, 2001 / Accepted: November 28, 2001
About this article
Cite this article
Yamamoto, T., Ozono, K., Shima, M. et al. Alendronate and pharmacological doses of 1α OHD3 therapy in a patient with McCune-Albright syndrome and accompanying hypophosphatemia. J Bone Miner Metab 20, 170–173 (2002). https://doi.org/10.1007/s007740200024
Issue Date:
DOI: https://doi.org/10.1007/s007740200024